Present preliminary clinical data from FIT-001 trial for KO-2806 as monotherapy and combination
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 5 Feb 2025
- Due
- 31 Dec 2025
- Delivered
- October 2025
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Present preliminary clinical data from FIT-001 trial for KO-2806 as monotherapy and combo with cabozantinib in RCC 2H 2025”
What we found
Evidence strength B What the grades mean
Kura Oncology presented preliminary FIT-001 clinical data on KO-2806 monotherapy and combination with cabozantinib at the ESMO Congress in October 2025, within the 2H 2025 deadline.
-
B Kura Oncology Reports Darlifarnib Plus Cabozantinib Demonstrates Robust Activity... References data build on ESMO 2025 findings, confirming prior presentation
-
B Kura Oncology Reports Second Quarter 2025 Financial Results States FIT-001 RCC and monotherapy data to be presented at ESMO, October 2025
-
C Kura Oncology to Present Darlifarnib Plus Cabozantinib Data ... at IKCS Europe 2026 Confirms earlier FIT-001 data were reported at 2025 ESMO Congress
Checked 15 Sep 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical readout
- Indicative materiality
- Medium rules
- Action
- Present
How this entry was checked
- Commitment recordedRecorded from the company's filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Gemini (Google), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Kura Oncology, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2025-KURA-000262 · Corrections policy